You have 9 free searches left this month | for more free features.

tamoxifen

Showing 26 - 50 of 162

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Breast Cancer Trial in Jakarta (Tamoxifen)

Active, not recruiting
  • Breast Cancer
  • Tamoxifen
  • Jakarta, DKI Jakarta, Indonesia
    MRCCC Siloam Hospitals Semanggi
Aug 12, 2022

Breast Cancer Trial in Lexington, East Syracuse (TOL2506, Tamoxifen, Letrozole tablets)

Enrolling by invitation
  • Breast Cancer
  • Lexington, Kentucky
  • +1 more
Jan 9, 2023

Male Breast Cancer, Hormone Receptor-positive Breast Cancer, Hormone Receptor Negative Breast Carcinoma Trial in Boston

Not yet recruiting
  • Male Breast Cancer
  • +2 more
  • Tamoxifen
  • +3 more
  • Boston, Massachusetts
  • +1 more
Aug 12, 2022

Breast Cancer Trial (Fluzoparib, Anastrozole, Letrozole)

Not yet recruiting
  • Breast Cancer
  • (no location specified)
Jun 5, 2023

Breast Tumors Trial in Worldwide (Palbociclib, Placebo, Tamoxifen)

Active, not recruiting
  • Breast Neoplasms
  • Nagoya, Aichi, Japan
  • +22 more
Apr 4, 2022

ER-positive Breast Cancer, HER2-negative Breast Cancer, Stage IIB Breast Cancer Trial (Elacestrant, Tamoxifen, Letrozole 2.5mg)

Not yet recruiting
  • ER-positive Breast Cancer
  • +3 more
  • (no location specified)
Aug 22, 2022

Breast Cancer Trial in New York (Fulvestrant, Tamoxifen)

Terminated
  • Breast Cancer
  • New York, New York
  • +2 more
Apr 27, 2021

Breast Cancer, HER2-negative Breast Cancer, ER Positive Breast Cancer Trial in Stanford (Alpelisib, Tamoxifen, Infigratinib)

Not yet recruiting
  • Breast Cancer
  • +2 more
  • Stanford, California
    Stanford University
Nov 16, 2022

Breast Tumors Trial in Mönchengladbach (drug, diagnostic test, procedure)

Active, not recruiting
  • Breast Neoplasms
  • Perjeta Injectable Product
  • +13 more
  • Mönchengladbach, Germany
    Evangelisches Krankenhaus Bethesda Mönchengladbach
Oct 4, 2022

Breast Cancer Trial in Amsterdam (anthracycline-based, docetaxel and capecitabine, tamoxifen)

Completed
  • Breast Cancer
  • Amsterdam, Netherlands
    Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital
Nov 16, 2022

Breast Cancer Trial in Worldwide (Amcenestrant, Tamoxifen, Amcenestrant-matching )

Active, not recruiting
  • Breast Cancer
  • East Syracuse, New York
  • +52 more
Aug 18, 2022

Non Metastatic Breast Cancer Trial in Lyon, Paris, Saint Herblain (tamoxifen)

Completed
  • Non Metastatic Breast Cancer
  • tamoxifen
  • Lyon, France
  • +2 more
Mar 10, 2021

Breast Cancer, Early-stage Breast Cancer, High Risk Breast Carcinoma Trial in United States (Abemaciclib, Tamoxifen,

Not yet recruiting
  • Breast Cancer
  • +2 more
  • Boston, Massachusetts
  • +7 more
Aug 14, 2023

Breast Cancer, HER2-positive Trial in Houston (Zanidatamab, Letrozole, Tamoxifen)

Recruiting
  • Breast Cancer
  • HER2-positive
  • Houston, Texas
    M D Anderson Cancer Center
Jul 9, 2022

Breast Cancer Trial in Budapest (Tamoxifen, Goserelin, Letrozole 2.5Mg Tab)

Not yet recruiting
  • Breast Cancer
  • Tamoxifen
  • +9 more
  • Budapest, Hungary
    National Institute of Oncolgy
Nov 20, 2021

Early-stage Breast Cancer Trial (Cyclophosphamide, Methotrexate, Fluorouracil implant)

Completed
  • Early-stage Breast Cancer
  • (no location specified)
Oct 13, 2020

Breast Cancer, HER2-negative Breast Cancer, Node-negative Breast Cancer Trial in Lexington (Anastrozole 1mg, Letrozole 2.5mg,

Recruiting
  • Breast Cancer
  • +3 more
  • Anastrozole 1mg
  • +3 more
  • Lexington, Kentucky
    University of Kentucky Markey Cancer Center
Jan 3, 2022

Breast Cancer Trial in Netherlands (Anastrozole, Anastrozole+Fulvestrant, Tamoxifen)

Suspended
  • Breast Cancer
  • den Haag, ZH, Netherlands
  • +3 more
Jan 20, 2021

Breast Cancer Trial in Italy (tamoxifen, triptorelin, letrozole)

Active, not recruiting
  • Breast Cancer
  • tamoxifen
  • +3 more
  • Avellino, AV, Italy
  • +19 more
Mar 3, 2021

Ovarian Carcinoma Trial in France (Tamoxifen, Regorafenib)

Active, not recruiting
  • Ovarian Carcinoma
  • Angers, France
  • +25 more
Oct 6, 2021

Breast Cancer, Invasive Breast Cancer Trial in Milwaukee (Anastrozole, Letrozole, Exemestane)

Active, not recruiting
  • Breast Cancer
  • Invasive Breast Cancer
  • Milwaukee, Wisconsin
    Froedtert Hospital
Sep 16, 2021

Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive, HER2/Neu Negative Trial in United States (Anastrozole,

Active, not recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +6 more
  • Atlanta, Georgia
  • +9 more
Oct 12, 2022

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8

Recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +13 more
  • San Francisco, California
    University of California, San Francisco
Jan 6, 2023

HIV Trial in Puerto Rico, United States (Tamoxifen, Vorinostat, Antiretroviral drugs)

Active, not recruiting
  • HIV Infections
  • Tamoxifen
  • +2 more
  • Birmingham, Alabama
  • +13 more
Jan 13, 2022

Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer Trial in Hong Kong, Japan, Singapore (LEE011, Letrozole,

Completed
  • Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer
  • Hong Kong, Hong Kong
  • +14 more
Oct 25, 2022